Literature DB >> 8441370

Cognitive and emotional disturbances in multiple sclerosis.

W W Beatty1.   

Abstract

The nature, prevalence, and course of cognitive and emotional disturbances in multiple sclerosis (MS) are described in this article. Mild to moderate cognitive impairment is common in MS and may be more incapacitating than physical symptoms for some patients. Although existing neurologic and neuroimaging procedures can detect some cognitively impaired patients, they lack sensitivity. Development of a brief neuropsychological screening battery, suitable for routine clinical use, is an important objective that may be achieved in the near future.

Entities:  

Mesh:

Year:  1993        PMID: 8441370

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  6 in total

Review 1.  Current pharmacologic treatment of multiple sclerosis symptoms.

Authors:  P B Andersson; D E Goodkin
Journal:  West J Med       Date:  1996-11

2.  Quality of Life (QoL) in severely disabled multiple sclerosis patients: comparison of three QoL measures using multidimensional scaling.

Authors:  T C Lintern; J G Beaumont; P M Kenealy; R C Murrell
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

3.  A health-related quality of life measure for multiple sclerosis.

Authors:  B G Vickrey; R D Hays; R Harooni; L W Myers; G W Ellison
Journal:  Qual Life Res       Date:  1995-06       Impact factor: 4.147

Review 4.  Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option?

Authors:  Christopher Christodoulou; William S MacAllister; Nancy A McLinskey; Lauren B Krupp
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

5.  Possible effects of synaptic imbalances on oligodendrocyte-axonic interactions in schizophrenia: a hypothetical model.

Authors:  Bernhard J Mitterauer; Birgitta Kofler-Westergren
Journal:  Front Psychiatry       Date:  2011-04-12       Impact factor: 4.157

6.  Neurogenesis in the chronic lesions of multiple sclerosis.

Authors:  Ansi Chang; Maria C Smith; Xinghua Yin; Robert J Fox; Susan M Staugaitis; Bruce D Trapp
Journal:  Brain       Date:  2008-07-23       Impact factor: 13.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.